News
- News
Optimizing Astatine-211 Radiolabeling: New Research Highlights the Importance of Timing
Atley Solutions is proud to spotlight the groundbreaking research led by our own Ellinor Hansson, which sheds light on a crucial aspect of astatine-211 (At-211) radiochemistry
- Pressrelease
Atley installs Atley C100 at world class nuclear medicine research institute Arronax
Atley Solutions has successfully installed an Atley C100 module at Arronax, a world-leading nuclear medicine research institute in Nantes, France.
- Pressrelease
Atley Solutions and Nusano in collaboration to accelerate astatine-211 development
Atley Solutions and Nusano today announced a non-exclusive memorandum of understanding (MOU) to co-develop astatine-211 (At-211) solutions for the rapidly emerging applications of the isotope in oncology therapeutics.
- Pressrelease
Atley makes first delivery of the Atley C100 to US biotech customer
Atley Solutions announces the first sale, delivery and installation of the Atley C100 to a US based biotech customer.
- Pressrelease
Atley’s expansion plans highlighted in local media “Nya Wermlands-tidningen”
In a featured article in the local news media Nya Wermlands-tidningen (NWT) Atley Solutions’ recent development and future expansion plans are highlighted.
- Pressrelease
Atley Solutions has been selected as one of Sweden’s best startups by NyTeknik
Atley Solutions has for the third time been selected as one of Sweden’s 33 best startup companies in the prestigious “33-listan” presented by the magazine NyTeknik.
- Pressrelease
Atley Solutions has successfully installed the first commercial Atley C100 module at Minerva Imaging.
Atley Solutions has delivered and installed the first commercial unit at Minerva Imaging’s facilities in Denmark.
- Pressrelease
Atley Solutions introduces the first commercial module for
At-211 radiopharmaceutical manufacturing
Atley Solutions announces the launch of the Atley C100, the world’s first commercial module specifically designed for the manufacturing of At-211 (astatine-211) radiopharmaceuticals.
- Pressrelease
Atley Solutions Announces Involvement in Thera4Care
Atley Solutions partners with GE HealthCare and a European consortium to expand the use of theranostics in cancer care, with a specific focus on improving the supply and production of astatine-211 radiopharmaceuticals.
